Related Experiment Videos
Ofloxacin vs ciprofloxacin: a comparison
D Nicolau1, R Quintiliani, C H Nightingale
1Department of Pharmacy Services, Hartford Hospital.
Connecticut Medicine
|May 1, 1992
Summary
Ofloxacin and ciprofloxacin are fluoroquinolone antibiotics with distinct clinical uses. Ofloxacin shows greater efficacy in chlamydia, staphylococcal, and pneumococcal infections, and is safer with theophylline, making it a versatile choice.
Area of Science:
- Pharmacology
- Infectious Diseases
- Microbiology
Background:
- Ofloxacin and ciprofloxacin are broad-spectrum fluoroquinolone antibiotics.
- Both agents exhibit activity against various bacterial pathogens.
- Key differences exist in their antimicrobial spectrum, clinical applications, and drug interactions.
Purpose of the Study:
- To compare the antimicrobial activity, clinical utility, and pharmacokinetic profiles of ofloxacin and ciprofloxacin.
- To delineate specific clinical scenarios where one agent may be preferred over the other.
- To inform therapeutic decisions in treating bacterial infections.
Main Methods:
- Comparative analysis of antimicrobial activity against key pathogens.
- Review of clinical utility in various infection types.
- Evaluation of pharmacokinetic and drug interaction profiles.
Main Results:
- Ofloxacin demonstrates superior activity against Chlamydia trachomatis, Staphylococcus species, and Streptococcus pneumoniae.
- Ciprofloxacin exhibits enhanced activity against gram-negative bacilli.
- Ofloxacin has a longer half-life, higher serum levels, and does not significantly interact with theophylline.
Conclusions:
- Ofloxacin is a preferred agent for urethritis, staphylococcal infections, pneumococcal pneumonia, and in patients taking theophylline.
- Both fluoroquinolones are effective against gram-negative organisms, but ofloxacin offers broader utility in mixed or specific infections.
- Therapeutic selection should consider pathogen susceptibility, infection site, and potential drug interactions.